Berkshire Partners Leads Investment to Combine Forcura and Medalogix
March 1, 2025
Forcura and Medalogix have combined to create a unified post-acute care technology platform, with Berkshire Partners as majority owner and The Vistria Group as the largest minority shareholder. The deal brings together Forcura's workflow and care coordination capabilities with Medalogix's clinical decision support and analytics to improve home-based care delivery and outcomes.
- Buyers
- Berkshire Partners, The Vistria Group
- Targets
- Forcura, Medalogix
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Vistria Group Recapitalizes Medalogix; Muse Healthcare Consolidates Under Medalogix
May 19, 2021
Healthcare Services
The Vistria Group led a recapitalization and growth investment in Medalogix and Muse Healthcare, consolidating the two data-science and machine-learning businesses under the Medalogix brand to expand clinical decision‑support capabilities for home health, palliative and hospice providers. Minority equity investors in the transaction include LHC Group, Amedisys Home Health and Hospice, and Encompass Health, which will help accelerate adoption across a large nationwide provider footprint.
-
Accel-KKR Makes Growth Investment in Forcura
July 16, 2020
Cloud & SaaS
Accel-KKR, a technology-focused private equity firm, made a significant growth investment in Forcura to accelerate the company's product innovation, growth and expansion across the post-acute care continuum. Forcura is a Jacksonville, Florida–based healthcare software provider offering a SaaS platform for care coordination, referral management and data-driven communication for home health, hospice and other post-acute providers.
-
General Atlantic Acquires Majority Stake in CareMetx; Vistria Reinvests
January 14, 2021
Healthcare Services
General Atlantic has entered a strategic growth partnership to become the majority owner of CareMetx, a Bethesda-based technology-enabled hub services company that supports patient access to specialty medications. Existing majority shareholder The Vistria Group is reinvesting and Marty Nesbitt (Vistria) will serve as CareMetx chairman; financial terms were not disclosed.
-
Veritas Capital Acquires Coronis Health and MiraMed Global Services to Create Scaled RCM Platform
August 4, 2022
Healthcare Services
An affiliate of Veritas Capital acquired Coronis Health from 424 Capital and other minority shareholders and acquired MiraMed Global Services from the Mira family, combining the two companies into a single, scaled revenue cycle management (RCM) platform. The combined business, led by Coronis CEO Stephen Grubbs with MiraMed founder Tony Mira as Vice Chairman, will provide end-to-end, technology-enabled RCM solutions across multiple specialties and employ over 8,500 people globally.
-
PointClickCare Acquires Collective Medical
December 30, 2020
Cloud & SaaS
PointClickCare Technologies has completed the acquisition of Collective Medical, combining PointClickCare's cloud-based post-acute dataset with Collective Medical's real-time, cross-continuum care coordination network. The deal brings together complementary SaaS platforms to provide deeper, point-of-care patient insights across acute, ambulatory, post-acute and payer settings; terms were not disclosed.
-
Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates
June 16, 2021
Healthcare Services
Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.